Compare BridgeBio Pharma Inc (BBIO) vs Toyota Motor Corp (TM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Toyota Motor Corp — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Toyota Motor Corp trades at $176.77 (market cap $205.39B). The key difference: Toyota Motor Corp is far larger — about 12.6× BridgeBio Pharma Inc's market cap, and Toyota Motor Corp pays a 3.59% dividend while BridgeBio Pharma Inc pays none. Which is the better fit depends on your goals.
| BBIO | TM | |
|---|---|---|
Market Cap | $16.27B | $205.39B |
Sector | Health | Consumer Cyclical |
52-Week High | $90.17 | $248.29 |
52-Week Low | $44.81 | $166.50 |
Enterprise Value | $17.82B | $369.58B |
Dividend Yield | — | 3.59% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Toyota Motor Corp
Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →
